Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvan Devaux

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
European Heart Journal|March 8, 2023
Targeting regulatory RNAs at the heart of Parkinson's diseaseShubhra Acharya, Andrew I Lumley, Yvan Devaux
Frontiers in Molecular Biosciences|March 14, 2022
Editorial: The Non-Coding Transcriptome as a New Player in Intercellular CommunicationYvan Devaux, Florence Pinet, David de Gonzalo-Calvo
Food & Function|June 21, 2024
Biomarkers of food intake and their relevance to metabolic syndromeMiguel Cifuentes, Farhad Vahid, Yvan Devaux, et al.
European Heart Journal|April 12, 2023
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease researchMiron Sopic, Georgios Kararigas, Yvan Devaux, et al.
Trends in Molecular Medicine|June 14, 2022
Methodological considerations for circulating long noncoding RNA quantificationDavid de Gonzalo-Calvo, Miron Sopić, Yvan Devaux, et al.
Clinical Chemistry and Laboratory Medicine|May 15, 2024
Navigating the path of reproducibility in microRNA-based biomarker research with ring trialsMiron Sopić, Yvan Devaux, David de Gonzalo-Calvo
International Journal of Molecular Sciences|January 25, 2020
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and CardioprotectionBranislav Kura, Barbora Kalocayova, Yvan Devaux, et al.
Clinical and Translational Science|March 2, 2012
Prediction of adverse cardiovascular events of noncardiovascular drugs through drug-target interaction networksFrancisco J Azuaje, Yvan Devaux, Daniel R Wagner
Journal of the American College of Cardiology|May 21, 2013
Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrestPascal Stammet, Daniel R Wagner, Georges Gilson, et al.
International Journal of Cardiology|July 23, 2013
Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarctionEmeline Goretti, Mélanie Vausort, Daniel R Wagner, et al.
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
European Heart Journal|March 8, 2023
Targeting regulatory RNAs at the heart of Parkinson's diseaseShubhra Acharya, Andrew I Lumley, Yvan Devaux
Frontiers in Molecular Biosciences|March 14, 2022
Editorial: The Non-Coding Transcriptome as a New Player in Intercellular CommunicationYvan Devaux, Florence Pinet, David de Gonzalo-Calvo
Food & Function|June 21, 2024
Biomarkers of food intake and their relevance to metabolic syndromeMiguel Cifuentes, Farhad Vahid, Yvan Devaux, et al.
European Heart Journal|April 12, 2023
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease researchMiron Sopic, Georgios Kararigas, Yvan Devaux, et al.
Trends in Molecular Medicine|June 14, 2022
Methodological considerations for circulating long noncoding RNA quantificationDavid de Gonzalo-Calvo, Miron Sopić, Yvan Devaux, et al.
Clinical Chemistry and Laboratory Medicine|May 15, 2024
Navigating the path of reproducibility in microRNA-based biomarker research with ring trialsMiron Sopić, Yvan Devaux, David de Gonzalo-Calvo
International Journal of Molecular Sciences|January 25, 2020
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and CardioprotectionBranislav Kura, Barbora Kalocayova, Yvan Devaux, et al.
Clinical and Translational Science|March 2, 2012
Prediction of adverse cardiovascular events of noncardiovascular drugs through drug-target interaction networksFrancisco J Azuaje, Yvan Devaux, Daniel R Wagner
Journal of the American College of Cardiology|May 21, 2013
Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrestPascal Stammet, Daniel R Wagner, Georges Gilson, et al.
International Journal of Cardiology|July 23, 2013
Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarctionEmeline Goretti, Mélanie Vausort, Daniel R Wagner, et al.
Pageof 21